vs
Side-by-side financial comparison of Dianthus Therapeutics, Inc. (DNTH) and Sidus Space Inc. (SIDU). Click either name above to swap in a different company.
Sidus Space Inc. is the larger business by last-quarter revenue ($366.0K vs $284.0K, roughly 1.3× Dianthus Therapeutics, Inc.). Sidus Space Inc. runs the higher net margin — -3115.2% vs -22687.3%, a 19572.2% gap on every dollar of revenue. On growth, Sidus Space Inc. posted the faster year-over-year revenue change (-16.2% vs -78.6%). Sidus Space Inc. produced more free cash flow last quarter ($-6.5M vs $-47.1M). Over the past eight quarters, Sidus Space Inc.'s revenue compounded faster (-43.8% CAGR vs -44.6%).
Dianthus Therapeutics is a clinical-stage biopharmaceutical firm focused on developing targeted therapies for rare immunological and inflammatory diseases. It advances antibody-based candidates to address unmet needs of severe patients, operating primarily in the U.S. with global development partners.
Sidus Space Inc is a U.S.-headquartered space technology and services provider specializing in small satellite design, manufacturing and operation. It offers end-to-end space solutions including data analytics, on-orbit servicing and custom hardware for commercial, government and academic clients worldwide, supporting various space mission objectives.
DNTH vs SIDU — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $284.0K | $366.0K |
| Net Profit | $-64.4M | $-11.4M |
| Gross Margin | — | -474.9% |
| Operating Margin | -24486.3% | -3009.2% |
| Net Margin | -22687.3% | -3115.2% |
| Revenue YoY | -78.6% | -16.2% |
| Net Profit YoY | -126.6% | -100.9% |
| EPS (diluted) | $-1.53 | $-0.29 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $284.0K | $366.0K | ||
| Q3 25 | $396.0K | $559.1K | ||
| Q2 25 | — | $691.1K | ||
| Q1 25 | $1.2M | — | ||
| Q4 24 | $1.3M | $436.5K | ||
| Q3 24 | $2.2M | $1.8M | ||
| Q2 24 | $1.9M | $834.8K | ||
| Q1 24 | $874.0K | $845.1K |
| Q4 25 | $-64.4M | $-11.4M | ||
| Q3 25 | $-36.8M | $-6.0M | ||
| Q2 25 | — | $-5.6M | ||
| Q1 25 | $-29.5M | — | ||
| Q4 24 | $-28.4M | $-5.7M | ||
| Q3 24 | $-25.2M | $-3.9M | ||
| Q2 24 | $-17.6M | $-4.1M | ||
| Q1 24 | $-13.7M | $-3.8M |
| Q4 25 | — | -474.9% | ||
| Q3 25 | — | -232.3% | ||
| Q2 25 | — | -148.6% | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -171.8% | ||
| Q3 24 | — | 2.2% | ||
| Q2 24 | — | -100.8% | ||
| Q1 24 | — | 9.9% |
| Q4 25 | -24486.3% | -3009.2% | ||
| Q3 25 | -10173.7% | -1007.2% | ||
| Q2 25 | — | -765.5% | ||
| Q1 25 | -2852.7% | — | ||
| Q4 24 | -2406.9% | -1165.4% | ||
| Q3 24 | -1376.6% | -180.5% | ||
| Q2 24 | -1191.8% | -466.9% | ||
| Q1 24 | -2041.6% | -421.4% |
| Q4 25 | -22687.3% | -3115.2% | ||
| Q3 25 | -9284.1% | -1079.2% | ||
| Q2 25 | — | -814.0% | ||
| Q1 25 | -2537.5% | — | ||
| Q4 24 | -2144.8% | -1300.0% | ||
| Q3 24 | -1159.0% | -222.1% | ||
| Q2 24 | -945.1% | -495.5% | ||
| Q1 24 | -1573.0% | -450.9% |
| Q4 25 | $-1.53 | $-0.29 | ||
| Q3 25 | $-0.97 | $-0.24 | ||
| Q2 25 | — | $-0.31 | ||
| Q1 25 | $-0.82 | — | ||
| Q4 24 | $-0.76 | $-0.26 | ||
| Q3 24 | $-0.74 | $-0.93 | ||
| Q2 24 | $-0.51 | $-0.99 | ||
| Q1 24 | $-0.54 | $-1.42 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $404.3M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $493.4M | $50.6M |
| Total Assets | $530.9M | $66.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $404.3M | — | ||
| Q3 25 | $402.6M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $263.2M | — | ||
| Q4 24 | $275.2M | — | ||
| Q3 24 | $281.1M | — | ||
| Q2 24 | $360.7M | — | ||
| Q1 24 | $377.0M | — |
| Q4 25 | $493.4M | $50.6M | ||
| Q3 25 | $546.5M | $24.0M | ||
| Q2 25 | — | $14.3M | ||
| Q1 25 | $328.6M | — | ||
| Q4 24 | $352.5M | $23.5M | ||
| Q3 24 | $337.9M | $9.3M | ||
| Q2 24 | $358.2M | $13.1M | ||
| Q1 24 | $372.7M | $17.2M |
| Q4 25 | $530.9M | $66.1M | ||
| Q3 25 | $577.4M | $39.9M | ||
| Q2 25 | — | $29.7M | ||
| Q1 25 | $348.6M | — | ||
| Q4 24 | $374.0M | $37.7M | ||
| Q3 24 | $354.2M | $23.1M | ||
| Q2 24 | $369.0M | $21.8M | ||
| Q1 24 | $382.5M | $25.4M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-47.0M | $-4.1M |
| Free Cash FlowOCF − Capex | $-47.1M | $-6.5M |
| FCF MarginFCF / Revenue | -16591.9% | -1768.6% |
| Capex IntensityCapex / Revenue | 48.6% | 651.5% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-132.8M | $-28.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-47.0M | $-4.1M | ||
| Q3 25 | $-30.6M | $-6.2M | ||
| Q2 25 | — | $-4.6M | ||
| Q1 25 | $-27.6M | — | ||
| Q4 24 | $-27.4M | $-5.5M | ||
| Q3 24 | $-21.3M | $-2.7M | ||
| Q2 24 | $-14.5M | $-2.2M | ||
| Q1 24 | $-14.9M | $-5.4M |
| Q4 25 | $-47.1M | $-6.5M | ||
| Q3 25 | $-30.6M | $-7.7M | ||
| Q2 25 | — | $-6.0M | ||
| Q1 25 | $-27.7M | — | ||
| Q4 24 | $-27.5M | $-7.9M | ||
| Q3 24 | $-21.3M | $-3.8M | ||
| Q2 24 | $-14.5M | $-4.0M | ||
| Q1 24 | $-15.0M | $-7.6M |
| Q4 25 | -16591.9% | -1768.6% | ||
| Q3 25 | -7717.2% | -1369.2% | ||
| Q2 25 | — | -870.2% | ||
| Q1 25 | -2377.8% | — | ||
| Q4 24 | -2072.0% | -1811.7% | ||
| Q3 24 | -980.3% | -213.6% | ||
| Q2 24 | -780.7% | -477.9% | ||
| Q1 24 | -1713.2% | -905.0% |
| Q4 25 | 48.6% | 651.5% | ||
| Q3 25 | 1.3% | 256.8% | ||
| Q2 25 | — | 199.1% | ||
| Q1 25 | 2.1% | — | ||
| Q4 24 | 2.3% | 543.4% | ||
| Q3 24 | 1.2% | 58.9% | ||
| Q2 24 | 0.9% | 220.1% | ||
| Q1 24 | 3.7% | 263.9% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
